Xeris Biopharma Holdings Stock Is A Hold With Robust Performance Into 2024 (NASDAQ:XERS) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
31.07.2023 - Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that Xeris has . Seite 1
Xeris Biopharma Holdings, Inc. (NASDAQ:NASDAQ:XERS) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Allison Wey - SVP, IR & Corporate Communications Paul.